Patient Factor | Late Presenters | Very Late Presenters | ||
---|---|---|---|---|
 | OR (95% CI) | p value | OR (95% CI) | p value |
Sex | ||||
Male | Reference | Â | Â | Â |
Female | 0.49 (0.41-0.54) | < 0.001 | 0.21 (0.15-0.30) | < 0.001 |
Age Group | ||||
0-14 years | 0.33 (0.23-0.5) | < 0.001 | 0.23 (0.1-0.56) | 0.0005 |
15-24 years | 0.40 (0.30-0.50) | < 0.001 | 0.27 (0.15-0.5) | < 0.001 |
25-34 years | Reference | Â | Â | Â |
35-44 years | 1.47 (1.26-1.73) | < 0.001 | 2.34 (1.7-3.2) | < 0.001 |
45 years & above | 1.26 (1.02-1.56) | 0.034 | 1.9 (1.2-3.04) | 0.006 |
Transmission route | ||||
Heterosexual | Reference | Â | Â | Â |
HIV+ spouse | 0.32 (0.27-0.40) | < 0.001 | 0.10 (0.05-0.16) | < 0.001 |
Parent to child | 0.21 (0.13-0.34) | < 0.001 | 0.10 (0.03-0.35) | < 0.001 |
Transfusion recipient | 1.8 (1.4-2.3) | < 0.001 | 0.92 (0.6-1.4) | 0.72 |
IVDU | 0.49 (0.24-0.95) | 0.03 | 0.26 (0.05-1.2) | 0.06 |
Unsterile syringe use, Occupational exposure | 2.16 (1.03-4.5) | 0.04 | 2.3 (0.42-12.8) | 0.32 |
MSM | 3.4 (0.35-32.73) | 0.26 | 3.5 (0.14-85.7) | 0.28 |
Unknown, undisclosed | 1.3 (1.1-1.54) | 0.003 | 1.08 (0.77-1.5) | 0.6 |